Effects of bisphosphonates on the mechanical competence of normal and osteopenic skeletons;Efectos de los bisfosfonatos sobre la eficiencia mecanica de esqueletos normales u osteopenicos

Medicina

Volumn 57, Issue SUPPL. 1, 1997, Pages 83-92

  Ferretti, Jose L ^a,b,e   Cointry, Gustavo R ^a   Capozza, Ricardo F ^a,d   Mondelo, Nelida ^c   Peluffo, Virginia ^c   Chiappe, Angelina ^d   Meta, Margarita ^d   Alippi, Rosa M ^d  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Inst/Fund de Invest Metabolicas   (Argentina)

^c Gador SA   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

BONE MINERALIZATION; BONE STRENGTH; DENSITOMETRY; DRUG MECHANISM; HUMAN; OSTEOPENIA; REVIEW; SKELETON;

EID: 0030863129     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Currey JD. The mechanical properties of materials and the structure of bone. En: Currey JD (ed) The mechanical adaptation of bones. New Jersey: Princeton University Press, 1984; 3-37.
2. Recker RR. Low bone mass may not be the only cause of skeletal fragility in osteoporosis. Proc Soc Exp Biol Med 1989; 101: 272-4.
3. Turner CH. Toward a cure for osteoporosis: reversal of excessive bone fragility. Osteoporosis Int 1991; 2: 12-9.
4. Frost HM (ed). Introduction to a new skeletal physiology. Vol. I. Bone and bones Pueblo (USA): Pajaro Group 1995.
5. Schiessl H, Ferretti JL, Tysarczyk-Niemeyer G, et al. Noninvasive Bone Strength Index as analyzed by peripheral quantitative computed tomography (pQCT). En: Schōnau G (ed) Paediatric Osteology. New development in diagnostics and therapy. Amsterdam: Elsevier 1996; 141-5.
6. Ferretti JL, Capozza RF, Mondelo N, et al. Interrelationships between densitometric, geometric and mechanical properties of rat femurs. Inferences concerning mechanical regulation of bone modeling. J Bone Miner Res 1993; 8: 1389-96.
7. Ferretti JL. Perspectives of pQCT technology associated to biomechanical studies in skeletal research employing rat models. Bone 1995; 17 4 Suppl: S353-64.
8. Ferretti JL, Capozza RF, Zanchetta JR. Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone 1996; 18: 97-102.
9. Schneider P, Ferretti JL, Capozza RF, et al. Bone densitometric and biomechanical properties of the distal radius by noninvasive assessment. Osteoporosis Int 1996; 6 Suppl 1: 176.
10. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO study group. Ginebra: World Health Organization (Tech Rep Ser 843) 1994.
11. Amman P, Rizzoli R, Meyer JM et al. Pamidronate improves trabecular bone mass/strength and, in association with IGF-I, cortical bone quality in ovariectomized rats. Bone Miner 1994; 25 Suppl 1: S59.
12. Apseloff G, Girten B, Weisbrode SE, et al. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats. J Pharmacol Exp Ther 1993; 267: 515-21.
13. Cointry GR, Mondelo N, Zanchetta JR, et al. Intravenous olpadronate restores ovariectomy-affected bone strength. A mechanical, densitometric and tomographic (pQCT) study. Bone 1995; 17 Suppl 4: S373-8.
14. Cointry GR, Mondelo N, Peluffo V, et al. Effects of high oral doses of olpadronate on mouse femur mass, architecture and mineralization. A tomographic (pQCT) study. Bone 1996; 19 Suppl 3: 135S.
15. Einhorn T, Peter CP, Clair J, et al. Effects of alendronate on mechanical properties of bone in rats and dogs. J Bone Miner Res 1990; 5 Suppl 1: S97.
16. Ferretti JL, Cointry G, Capozza R. et al. Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)- 1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats. Bone Miner 1990; 11: 101-9.
17. Ferretti JL, Mondelo N, Capozza R, et al. Pamidronate and dimethyl-pamidronate effects on femur biomechanics in ovariectomized-hemisciaticectomized rats. Bone Miner 1992; 17 Suppl 1: S12.
18. Ferretti JL, Delgado CJ, Capozza R, et al. Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-induced osteopenia in growing rat femurs. Bone Miner 1993; 20: 265-76.
19. Ferretti JL, Mondelo N, Peluffo V, et al. Sub-chronic effects of high doses of mildronate on femur densitometric (DEXA), tomographic (pQCT) and mechanical properties in young rats. Bone Miner 1994; 25 Suppl 2: S12.
20. Ferretti JL. Effects of bisphosphonates on bone biomechanics. En: Bijvoet OLM et al (eds) bisphosphonate on bones. Amsterdam: Elsevier 1995; 211-29.
21. Ferretti JL, Mondelo N, Capozza RF, et al. Effects of large doses of olpadronate (dimethyl-pamidronate) on mineral density, cross-sectional architecture, and mechanical properties of rat femurs. Bone 1995; 16 Suppl 4: S285-93.
22. Ferretti JL, Chiappe A, Meta M, et al. Protective effects of alendronate against the negative impact of ovariectomy as assessed by peripheral computed tomography (pQCT) and bending tests in rat femurs. J Bone Miner Res 1995; 10 Suppl 1: S357.
23. Ferretti JL, Ma YP, Capozza RF, et al. Effects of pure and combined treatments with risedronate and hPTH (1-38) on rat femora and tibiae after immobilization or overloading. J Bone Miner Res 1996; 11 Suppl 1: S338.
24. Ferretti JL, Mondelo N, Cointry GR, et al. Efectos puros o combinados de la hPTH (1-32) y los bisfosfonatos pamidronato y olpadronato sobre la estructura y la biomecánica femoral en ratas (resumen). Medicina (Buenos Aires) 1996; 56: 606.
25. Glatt M, Pataki A, Blaetter A, et al. APD long-term treatment increases bone mass and mechanical strength of femora of adult mice. Calcif Tissue Int 1986; 39: A72.
26. Grynpas MD, Acito A, Dimitru M, et al. Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporosis Int 1992; 2: 74-81.
27. Guy JA, Shea N, Peter CP, et al. Continuous alendronate treatment through growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties. Calcif Tissue Int 1993; 283-8.
28. Lauritzen DB, Balena R, Shea M, et al. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 1993, 8: 871-9.
29. Ma YF, Ferretti JL, Capozza RF, et al. Effects of on/ off anabolic hPTH and remodeling inhibitors on metaphyseal bone of immobilized rat femora. Tomographical (pQCT) description and correlation with histomorphometric changes in tibial cancellous bone. Bone 1995; 17 Suppl 4: S321-8.
30. Rodan GA, Seedor JG, Balena R. Preclinical pharmacology of alendronate. Osteoporosis Int 1993; 3 Suppl 3: S7-12.
31. Thompson DD, Seedor JG, Weinreb N, et al. Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats. J Bone Miner Res 1990; 5: 279-86.
32. Toolan BC, Shea M, Myers ER, et al. The effect of long term alendronate treatment on vertebral strength in ovariectomized baboons and rats. J Bone Miner Res 1991; 6 Suppl 1: S248.
33. Bijvoet OLM, Canfield R, Fleisch H, et al (eds). Bisphosphonate on Bones. Amsterdam: Elsevier 1995.
34. Jagger CJ, Chambers TJ, Chow JWM. Stimulation of bone formation by dynamic mechanical loading of rat caudal vertebrae is not suppressed by 3-amino-1-hydroxypropylidene-1-bisphosphonate (AHPrBP). Bone 1995; 16: 309-13.
35. Massari F, Varela Otero P, Zanchetta JR. Efectos del tratamiento con alendronato sobre los niveles de PTH sérica en mujeres con Osteoporosis postmenopáusica, Rev Arg Endocrinol Metab 1996; 33 Suppl. I: 48.